BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26025680)

  • 1. JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation.
    Huang X; Zhang S; Qi H; Wang Z; Chen HW; Shao J; Shen J
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2286-95. PubMed ID: 26025680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
    Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
    Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.
    Zhang K; Wu J; Wu X; Wang X; Wang Y; Zhou N; Kuo ML; Liu X; Zhou B; Chang L; Ann D; Yen Y
    Mol Cancer Ther; 2011 Feb; 10(2):269-78. PubMed ID: 21216934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway.
    Yao Y; Zhou WY; He RX
    Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jmjd5 functions as a regulator of p53 signaling during mouse embryogenesis.
    Ishimura A; Terashima M; Tange S; Suzuki T
    Cell Tissue Res; 2016 Mar; 363(3):723-33. PubMed ID: 26334721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression.
    Ishimura A; Minehata K; Terashima M; Kondoh G; Hara T; Suzuki T
    Development; 2012 Feb; 139(4):749-59. PubMed ID: 22241836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells.
    Zhu H; Hu S; Baker J
    Stem Cells; 2014 Aug; 32(8):2098-110. PubMed ID: 24740926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
    Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
    Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx.
    Kouwaki T; Okamoto T; Ito A; Sugiyama Y; Yamashita K; Suzuki T; Kusakabe S; Hirano J; Fukuhara T; Yamashita A; Saito K; Okuzaki D; Watashi K; Sugiyama M; Yoshio S; Standley DM; Kanto T; Mizokami M; Moriishi K; Matsuura Y
    J Virol; 2016 Jan; 90(7):3530-42. PubMed ID: 26792738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
    Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
    Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.
    Yousefi B; Rahmati M; Ahmadi Y
    Life Sci; 2014 Mar; 99(1-2):14-7. PubMed ID: 24486301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.
    Schumm K; Rocha S; Caamano J; Perkins ND
    EMBO J; 2006 Oct; 25(20):4820-32. PubMed ID: 16990795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
    Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
    Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase JMJD5 is essential for embryonic development.
    Oh S; Janknecht R
    Biochem Biophys Res Commun; 2012 Mar; 420(1):61-5. PubMed ID: 22402282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
    Nardinocchi L; Puca R; Sacchi A; D'Orazi G
    Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the JmjC-domain-containing protein JMJD5.
    Wang H; Zhou X; Wu M; Wang C; Zhang X; Tao Y; Chen N; Zang J
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):1911-20. PubMed ID: 24100311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
    Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
    Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.